Zevra Therapeutics Presents Design of Phase 2 Clinical

Zevra is a corporate sponsor of the Hypersomnia Foundation and Beyond Sleepy Conference CELEBRATION, Fla., June 03, 2023 (GLOBE NEWSWIRE) -- Zevra...

Related Keywords

Nichol Ochsner ,Jennifer Arcure ,Christal Mickle ,Rene Braeckman ,Christopher Drake ,Corium Inc ,Us Drug Enforcement Agency ,Hypersomnia Foundation ,Company Early Access Program ,Zevra Therapeutics Inc ,Clinical Development ,Henry Ford Health ,Drug Administration ,European Medicines Agency ,Exchange Commission ,Beyond Sleepy ,Sleepy Conference ,Beyond Sleep ,Chief Executive Officer ,Chief Development Officer ,Orphan Drug Designation ,Clinical Study ,Vice President ,Sleep Research ,Associated Professional Sleep Societies ,Enforcement Agency ,Fast Track ,Breakthrough Therapy ,New Drug Application ,Zevra Therapeutics ,Early Access Program ,Concerning Forward Looking Statements ,Private Securities Litigation Reform Act ,Investigational New Drug ,Annual Report ,Quarterly Report ,Nasdaq Zvra ,